Carsgen Therapeutics

formerly CARsgen (科济药业)IPO

Carsgen Therapeutics is a biotech company in Shanghai, China, founded in 2014. It has raised $245.0M across 4 rounds, most recently a $186.0M Series C in November 2020.

Headquarters
Shanghai
Employees
51–200
Founded
2014
Business Model
B2B
Total Funding
$245.0M
Last Round
$186.0M Series CNov 2020
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 7 investors for this company. The full record is or through the API.

About

CARsgen Therapeutics is a biopharmaceutical company founded in 2014 in Shanghai that develops innovative CAR T-cell therapies targeting hematologic malignancies and solid tumors. The company has built an integrated cell therapy platform with in-house capabilities spanning target discovery, antibody development, clinical trials, and commercial-scale manufacturing. Its lead approved product, zevorcabtagene autoleucel (CT053), received China NMPA approval for multiple myeloma treatment, making CARsgen a pioneer in both hematology and solid tumor CAR-T programs. The company operates across China and the United States and is publicly listed on the Hong Kong Stock Exchange.

Summary

It lists 51–200 employees. It has raised $245.0M in total across 4 rounds, most recently a $186.0M Series C round in Nov 2020. Investors include Loyal Valley Capital, KTB Network and BVCF.

Funding & Exit History

Data from Indexed.vcUpdated
IPOJun 2021
$400.0M

Sign up to see all 5 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Carsgen Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/carsgen-therapeutics"><img src="https://indexed.vc/api/badge/company/carsgen-therapeutics" alt="Carsgen Therapeutics on Indexed.vc" width="260" height="76" /></a>